MediWound Ltd. (MDWD)
$12.22-2.71%Close
SELLRECOVERY · day 29
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $157M
- Beta
- 0.14
- P/E (TTM)
- -7.64
- Short % float
- 19.28%
- Days to cover
- 28.2
- SI change
- +1.7%
- 1W
- -7.07%
- 1M
- -11.96%
- vs SPY 1W
- -6.93%
- vs SPY 1M
- -14.47%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 1
- GROWTH
- 6
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-28.3%
REV YoY-
ROE-47.2%
EPS YoY-
ROA-28.1%
GROSS15
OP-268
NET-170
[VALUATION]
P/E TTM-7.64
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B4.42
P/FCF-
EV/EBITDA-8.53
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E26.76
ALTMAN Z-
CURR RATIO2.32
ND/EBITDA-
BETA0.14
Company news
FAQ
- What is LOPJLB’s current signal on MDWD?
- LOPJLB’s latest quantitative signal on MediWound Ltd. (MDWD) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is MDWD in?
- MediWound Ltd. (MDWD) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does MediWound Ltd. (MDWD) do?
- MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn c…